Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer
- PMID: 22866215
- PMCID: PMC3406190
- DOI: 10.4111/kju.2012.53.7.457
Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer
Abstract
Purpose: Tumor size and multiplicity are known to be important prognostic factors in non-muscle-invasive bladder cancer (NMIBC). However, evaluation of accurate tumor size is subjective and difficult. Furthermore, there are limitations to the objectification of tumor volume in the case of multiple lesions. In this study, we investigated the relation between resection weight after transurethral resection of bladder tumor (TURBT) and the prognosis of NMIBC.
Materials and methods: This was a retrospective analysis of 406 patients diagnosed with pTa or pT1 bladder tumors after TURBT between September 1999 and May 2010. The patient's age, sex, underlying diseases, cancer stage, grade, multiplicity, tumor size, lymphovascular invasion, and resection weight were analyzed in relation to cancer progression and recurrence. The resection weight was weighted after formaldehyde fixation.
Results: The mean follow-up time was 76.9 months (range, 12 to 167 months) in 406 patients diagnosed as having NMIBC. Mean resection weight was 4.5 g (range, 0.1 to 35.0 g). The cancer recurred in 99 patients (24.4%), and disease progression was noted in 30 patients (7.4%). Resection weight was categorized as greater than or less than 2 g by use of receiver operator characteristic curves. Cancer grade (p=0.022) and multiplicity (p=0.043) were significantly related to cancer recurrence in the analysis with Cox's multivariate proportional hazard model. Cancer grade (p=0.001) and resection weight (p=0.018) were related to disease progression.
Conclusions: Resection weight after TURBT was significantly related to progression of NMIBC. Resection weight was an independent factor of progression. Further management should be considered if the resection weight exceeds 2 g.
Keywords: Prognosis; Tumor burden; Urinary bladder neoplasms.
Conflict of interest statement
The authors have nothing to disclose.
Figures



Similar articles
-
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5. Eur Urol. 2020. PMID: 31699526
-
Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.PLoS One. 2017 Dec 15;12(12):e0189354. doi: 10.1371/journal.pone.0189354. eCollection 2017. PLoS One. 2017. PMID: 29244843 Free PMC article.
-
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272. Arch Ital Urol Androl. 2017. PMID: 29473376
-
The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis.J Endourol. 2020 Aug;34(8):795-804. doi: 10.1089/end.2020.0301. Epub 2020 Jun 3. J Endourol. 2020. PMID: 32336149
-
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.Eur Urol. 2009 Sep;56(3):430-42. doi: 10.1016/j.eururo.2009.06.028. Epub 2009 Jun 26. Eur Urol. 2009. PMID: 19576682 Review.
Cited by
-
Low Preoperative Lymphocyte-to-Monocyte Ratio Is Predictive of the 5-Year Recurrence of Bladder Tumor after Transurethral Resection.J Pers Med. 2021 Sep 23;11(10):947. doi: 10.3390/jpm11100947. J Pers Med. 2021. PMID: 34683088 Free PMC article.
-
A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens.BJU Int. 2019 Jan;123(1):11-21. doi: 10.1111/bju.14417. Epub 2018 Jun 29. BJU Int. 2019. PMID: 29807387 Free PMC article.
References
-
- National Cancer Center [internet] The statistics report: the incidence of cancer on 2003-2005 and the survival rate on 1993-2005. Goyang: National Cancer Center; c2012. [cited 2009 Apr 1]. Available from: http://www.ncc.re.kr.
-
- Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
-
- Kim YJ, Moon KH, Kim KR, Kim CS. Significance of T1 substaging on the recurrence and progression of bladder cancer. Korean J Urol. 2000;41:1323–1328.
-
- Kwon S, Park CM, Kim HG, Gang GH, Song JS, Park JY. Prognostic significance of the tumor configuration in superficial bladder tumor. Korean J Urol. 2006;47:237–243.
-
- Reading J, Hall RR, Parmar MK. The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice. Br J Urol. 1995;75:604–607. - PubMed
LinkOut - more resources
Full Text Sources